规格
|
Assay Entry:
|
Cell-based beta lactamase reporter gene |
Cell State:
|
Dividing Cells |
Detection Method:
|
Fluorescent |
Druggable Target:
|
Nuclear Receptors |
Primary Agonist:
|
Calcitriol |
Product Line:
|
GeneBLAzer® |
Reporter Gene:
|
BLA (Beta-Lactamase) |
System Type:
|
GeneBLAzer™ |
Target Entry:
|
PPARG, PPAR gamma, NR1C3 |
储存
|
Shipping: Dry IceStorage: -80°C/Liquid NitrogenContains: PPAR gamma-UAS-bla 293H cells (K1094) |
PPAR gamma-UAS-bla HEK 293H cells contain the ligand-binding domain (LBD) of the human Peroxisome Proliferator-Activated Receptor-gamma (PPAR gamma) fused to the DNA-binding domain of GAL4 stably integrated in the GeneBLAzer®UAS-bla HEK 293H cell line. GeneBLAzer®UAS-bla HEK 293H cells stably express a beta-lactamase reporter gene under the transcriptional control of an upstream activator sequence (UAS). When an agonist binds to the LBD of the GAL4 (DBD)-PPAR gamma (LBD) fusion protein, the protein binds to the UAS, resulting in expression of beta-lactamase. Division Arrested (DA) cells are available in two configurations- an Assay Kit (which includes cells and sufficient substrate to analyze 1 x 384-well plate), and a tube of cells sufficient to analyze 10 x 384-well plates. PPAR gamma-UAS-bla HEK 293H cells are functionally validated for Z' and EC50 concentrations of Rosiglitazone. In addition, PPAR gamma-UAS-bla HEK 293H cells have been tested for assay performance under variable conditions, including DMSO concentration, cell number, and stimulation time.